Guideline for PET/CT imaging of neuroendocrine neoplasms with 68Ga-DOTA-conjugated somatostatin receptor targeting peptides and 18F–DOPA
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Guideline for PET/CT imaging of neuroendocrine neoplasms with 68Ga-DOTA-conjugated somatostatin receptor targeting peptides and 18F–DOPA
Authors
Keywords
Neuroendocrine tumours, Neuroendocrine neoplasms, Pet/Ct, <sup>68</sup>Ga-DOTATATE, <sup>68</sup>Ga-DOTATOC, <sup>68</sup>Ga-DOTANOC, <sup>18</sup>F–DOPA, <sup>18</sup>F–FDG, Thyroid medullary cancer, Pheochromoacytoma, Paraganglioma, Foregut-NET, Midgut-NET, Hindgut-NET, Hyperinsulism in infants
Journal
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
Volume 44, Issue 9, Pages 1588-1601
Publisher
Springer Nature
Online
2017-05-25
DOI
10.1007/s00259-017-3728-y
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Current knowledge on the sensitivity of the 68Ga-somatostatin receptor positron emission tomography and the SUVmax reference range for management of pancreatic neuroendocrine tumours
- (2016) Irene Virgolini et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Recommended administered activities for 68Ga-labelled peptides in paediatric nuclear medicine
- (2016) J. Soares Machado et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Direct comparison of 68Ga-DOTA-TOC and 18F-FDG PET/CT in the follow-up of patients with neuroendocrine tumour treated with the first full peptide receptor radionuclide therapy cycle
- (2016) Bernhard Nilica et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- From preclinical development to clinical application: Kit formulation for radiolabelling the minigastrin analogue CP04 with In-111 for a first-in-human clinical trial
- (2016) Dariusz Pawlak et al. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
- Dynamic 18F-FDOPA PET Findings After Carbidopa Premedication in 2 Adult Patients With Insulinoma-Related Hyperinsulinemic Hypoglycemia
- (2015) Alessio Imperiale et al. CLINICAL NUCLEAR MEDICINE
- Peptide receptor radionuclide therapy (PRRT): clinical significance of re-treatment?
- (2015) Irene Virgolini et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Multiparametric PET imaging in thyroid malignancy characterizing tumour heterogeneity: somatostatin receptors and glucose metabolism
- (2015) Tatjana Traub-Weidinger et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- 68Ga-Based Radiopharmaceuticals: Production and Application Relationship
- (2015) Irina Velikyan MOLECULES
- 18F-FDOPA PET/CT imaging of insulinoma revisited
- (2014) Alessio Imperiale et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- 68Ga-DOTA0-Tyr3-octreotide positron emission tomography in head and neck squamous cell carcinoma
- (2013) Volker H. Schartinger et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Comparison of 68Ga-DOTANOC and 68Ga-DOTATATE PET/CT Within Patients with Gastroenteropancreatic Neuroendocrine Tumors
- (2013) D. Wild et al. JOURNAL OF NUCLEAR MEDICINE
- Measured Human Dosimetry of 68Ga-DOTATATE
- (2013) R. C. Walker et al. JOURNAL OF NUCLEAR MEDICINE
- Peptide receptor radionuclide therapy of neuroendocrine tumors with 90Y-DOTATOC: Is treatment response predictable by pre-therapeutic uptake of 68Ga-DOTATOC?
- (2013) M.Ö. Öksüz et al. Diagnostic and Interventional Imaging
- Feasibility of Carbidopa Premedication in Pediatric Patients: A Pilot Study
- (2012) Egesta Lopci et al. CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS
- Does the Pretherapeutic Tumor SUV in 68Ga DOTATOC PET Predict the Absorbed Dose of 177Lu Octreotate?
- (2012) Samer Ezziddin et al. CLINICAL NUCLEAR MEDICINE
- Comprehensive evaluation of a somatostatin-based radiolabelled antagonist for diagnostic imaging and radionuclide therapy
- (2012) Xuejuan Wang et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Diagnostic performance of 18F-dihydroxyphenylalanine positron emission tomography in patients with paraganglioma: a meta-analysis
- (2012) Giorgio Treglia et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Comparison of 68Ga-DOTATATE and 68Ga-DOTANOC PET/CT imaging in the same patient group with neuroendocrine tumours
- (2012) Levent Kabasakal et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Somatostatin receptor PET in neuroendocrine tumours: 68Ga-DOTA0,Tyr3-octreotide versus 68Ga-DOTA0-lanreotide
- (2012) Daniel Putzer et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Feasibility and availability of 68Ga-labelled peptides
- (2012) Clemens Decristoforo et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Clinical PET of Neuroendocrine Tumors Using 64Cu-DOTATATE: First-in-Humans Study
- (2012) A. Pfeifer et al. JOURNAL OF NUCLEAR MEDICINE
- 18F-Fluorodeoxyglucose Positron Emission Tomography Predicts Survival of Patients with Neuroendocrine Tumors
- (2010) T. Binderup et al. CLINICAL CANCER RESEARCH
- Non FDG PET
- (2010) C. Nanni et al. CLINICAL RADIOLOGY
- 68Ga-DOTA-NOC PET/CT in comparison with CT for the detection of bone metastasis in patients with neuroendocrine tumours
- (2010) Valentina Ambrosini et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Standardized Uptake Values of 68Ga-DOTANOC PET: A Promising Prognostic Tool in Neuroendocrine Tumors
- (2010) D. Campana et al. JOURNAL OF NUCLEAR MEDICINE
- In vivo binding of [68Ga]-DOTATOC to somatostatin receptors in neuroendocrine tumours — impact of peptide mass
- (2010) Irina Velikyan et al. NUCLEAR MEDICINE AND BIOLOGY
- Comparison of three radiolabelled peptide analogues for CCK-2 receptor scintigraphy in medullary thyroid carcinoma
- (2009) Alida C. Fröberg et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- 68Ga-somatostatin analogues PET and 18F-DOPA PET in medullary thyroid carcinoma
- (2009) Valentina Ambrosini et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Detection of unknown primary neuroendocrine tumours (CUP-NET) using 68Ga-DOTA-NOC receptor PET/CT
- (2009) Vikas Prasad et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Comparison of 68Ga-DOTATATE and 18F-fluorodeoxyglucose PET/CT in the detection of recurrent medullary thyroid carcinoma
- (2009) Brendon G. Conry et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Limited Value of 18F-F-DOPA PET to Localize Pancreatic Insulin-Secreting Tumors in Adults with Hyperinsulinemic Hypoglycemia
- (2009) L. Tessonnier et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- A Comparison of 68Ga-DOTATATE and 18F-FDG PET/CT in Pulmonary Neuroendocrine Tumors
- (2009) I. Kayani et al. JOURNAL OF NUCLEAR MEDICINE
- Bone Metastases in Patients with Neuroendocrine Tumor: 68Ga-DOTA-Tyr3-Octreotide PET in Comparison to CT and Bone Scintigraphy
- (2009) D. Putzer et al. JOURNAL OF NUCLEAR MEDICINE
- 68Ga-DOTA-Tyr3-Octreotide PET for Assessing Response to Somatostatin-Receptor-Mediated Radionuclide Therapy
- (2009) M. Gabriel et al. JOURNAL OF NUCLEAR MEDICINE
- 68Ga-DOTA-NOC: a new PET tracer for evaluating patients with bronchial carcinoid
- (2009) Valentina Ambrosini et al. NUCLEAR MEDICINE COMMUNICATIONS
- Evaluation of unusual neuroendocrine tumours by means of 68Ga-DOTA-NOC PET
- (2008) Stefano Fanti et al. BIOMEDICINE & PHARMACOTHERAPY
- Functional imaging of neuroendocrine tumors with combined PET/CT using68Ga-DOTATATE (DOTA-DPhe1,Tyr3-octreotate) and18F-FDG
- (2008) Irfan Kayani et al. CANCER
- The clinical value of [18F]fluoro-dihydroxyphenylalanine positron emission tomography in primary diagnosis, staging, and restaging of neuroendocrine tumors
- (2008) Saila Kauhanen et al. ENDOCRINE-RELATED CANCER
- Comparison between 68Ga-DOTA-NOC and 18F-DOPA PET for the detection of gastro-entero-pancreatic and lung neuro-endocrine tumours
- (2008) Valentina Ambrosini et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Premedication With Carbidopa Masks Positive Finding of Insulinoma and β-Cell Hyperplasia in [18F]-Dihydroxy-Phenyl-Alanine Positron Emission Tomography
- (2008) Saila Kauhanen et al. JOURNAL OF CLINICAL ONCOLOGY
- 18F-Dihydroxyphenylalanine PET in Patients with Biochemical Evidence of Medullary Thyroid Cancer: Relation to Tumor Differentiation
- (2008) K. P. Koopmans et al. JOURNAL OF NUCLEAR MEDICINE
- Quantitative Gene Expression of Somatostatin Receptors and Noradrenaline Transporter Underlying Scintigraphic Results in Patients with Neuroendocrine Tumors
- (2008) Tina Binderup et al. NEUROENDOCRINOLOGY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started